ArticleMolecular pharmaceutics2026

Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer.

Harun Taş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.